Paul F Truex's Net Worth
Estimate Recalculated Sep 9, 2024 12:29AM EST
Who is Paul F Truex
Paul F Truex does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trius Therapeutics Inc, CymaBay Therapeutics, Inc., Milestone Pharmaceuticals Inc., and Anthera Pharmaceuticals Inc.
SEC CIK
Paul F Truex's CIK is 0001120362
Past Insider Trading and Trends
2022 was Paul F Truex's most active year for acquiring shares with 5 total transactions. Paul F Truex's most active month to acquire stocks was the month of April. 2013 was Paul F Truex's most active year for disposing of shares, totalling 5 transactions. Paul F Truex's most active month to dispose stocks was the month of August. 2022 saw Paul F Truex paying a total of $143,795.12 for 81,780 shares, this is the most they've acquired in one year. In 2013 Paul F Truex cashed out on 63,403 shares for a total of $521,670.63, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
